Targeted VNTR long read sequencing resolves a diagnostic bottleneck in ADTKD and detects de novo ADTKD-MUC1
Abstract
INTRODUCTION: The molecular diagnosis of autosomal dominant tubulointerstitial kidney disease due to MUC1 variants (ADTKD-MUC1) using high-throughput (short-read) sequencing methods remains challenging due to the presence of a coding long variable-number tandem repeat (VNTR) region wherein most known pathogenic variants are located. METHODS: Here, we used targeted amplicon long-read sequencing to study the MUC1 VNTR in a retrospective cohort study of 78 individuals. Using a bioinformatic pipeline including newly developed specialized software, VNTRtools, we reconstructed patient-specific complete VNTR haplotypes, generated a synthetic VNTR reference, performed long-read realignment to this reference, and finally performed variant calling. RESULTS: VNTRtools proved efficient, requiring seconds or minutes per sample to accurately identify all pathogenic MUC1 frameshift variants in positive controls, including atypical variants. Ten new diagnoses of ADTKD-MUC1 were made. Furthermore, we report a confirmed de novo case of ADTKD-MUC1 in a 32-year-old patient. We were able to structurally resolve and phase the interindividually highly variable VNTRs in most probands, enabling the high-confidence detection of pathogenic frameshift variants in 24 individuals. We also detected 18 previously unreported VNTR repeat unit types, demonstrating the highly polymorphic nature of MUC1's VNTR. CONCLUSIONS: We propose a combined approach in which short-read VNTR analysis using the published alignment-free bioinformatic tools is used as a first-line test, followed by targeted long-read sequencing with VNTRtools analysis for confirmatory testing and in-depth VNTR characterization. This combined approach will lead to a higher diagnostic confidence in ADTKD-MUC1-especially in sporadic cases. Complete VNTR haplotype information will likely enable a better genetic understanding of this currently underdiagnosed disorder and may become relevant for future therapeutic approaches like targeted silencing of the pathogenic MUC1 allele.
Authors 14
-
University of Cologne · University Hospital Cologne
Affiliation as printed
Institute of Human Genetics and Center for Rare and Hereditary Kidney Disease, Faculty of Medicine and University Hospital Cologne, Cologne, Germany
-
University of Cologne · University Hospital Cologne
Affiliation as printed
Institute of Human Genetics and Center for Rare and Hereditary Kidney Disease, Faculty of Medicine and University Hospital Cologne, Cologne, Germany
-
Friedrich-Alexander-Universität Erlangen-Nürnberg · Universitätsklinikum Erlangen
Affiliation as printed
Department of Nephrology and Hypertension, University Hospital Erlangen, Friedrich-Alexander University Erlangen-Nürnberg, Erlangen, Germany
-
University of Zagreb · University Hospital Dubrava
Affiliation as printed
Department of Nephrology and Dialysis, Dubrava University Hospital, Zagreb, Croatia; Faculty of Pharmacy and Biochemistry, University of Zagreb, Zagreb, Croatia
-
University Hospital Centre Zagreb
Affiliation as printed
Department of Nephrology, Faculty of Medicine and University Hospital Center Zagreb, Zagreb, Croatia
-
Affiliation as printed
Cologne Center for Genomics, Medical Faculty, University of Cologne, Cologne, Germany; West German Genome Center, University of Cologne, Cologne, Germany
-
University of Cologne · University Hospital Cologne
Affiliation as printed
Institute of Human Genetics and Center for Rare and Hereditary Kidney Disease, Faculty of Medicine and University Hospital Cologne, Cologne, Germany
-
Düsseldorf University Hospital · Universitätsklinikum Aachen · Heinrich Heine University Düsseldorf
Affiliation as printed
Department of Nephrology, Medical Faculty, University Hospital Düsseldorf, Heinrich-Heine-University Düsseldorf, Düsseldorf, Germany; Center of Excellence in Nephrology, University Hospitals Aachen, Cologne, Dusseldorf, North Rhine-Westphalia, Germany
-
Friedrich-Alexander-Universität Erlangen-Nürnberg · Universitätsklinikum Erlangen
Affiliation as printed
Institute of Human Genetics, University Hospital Erlangen, Friedrich-Alexander University Erlangen-Nürnberg, Erlangen, Germany
-
TUM Klinikum · Institut für Humangenetik · Technical University of Munich · Ludwig-Maximilians-Universität München
Affiliation as printed
Institute of Human Genetics, LMU University Hospital, LMU Medizin, Ludwig-Maximilians-Universität München, Munich, Germany; Institute of Human Genetics, Klinikum rechts der Isar, Technical University of Munich, TUM School of Medicine and Health, Munich, Germany
-
Friedrich-Alexander-Universität Erlangen-Nürnberg · Universitätsklinikum Erlangen
Affiliation as printed
Department of Nephrology and Hypertension, University Hospital Erlangen, Friedrich-Alexander University Erlangen-Nürnberg, Erlangen, Germany
-
Max Planck Institute for Plant Breeding Research
Affiliation as printed
Max Planck Genome Center, Max Planck Institute for Plant Breeding Research, Cologne, Germany
-
Florian Erger corresponding
Universitätsmedizin Greifswald · Universität Greifswald
Affiliation as printed
University Medicine Greifswald, Institute for Molecular Genomics, Core Unit Genomics, Greifswald, Germany. Electronic address: Florian.Erger@med.uni-greifswald.de
-
University of Cologne · University Hospital Cologne
Affiliation as printed
Institute of Human Genetics and Center for Rare and Hereditary Kidney Disease, Faculty of Medicine and University Hospital Cologne, Cologne, Germany. Electronic address: Bodo.Beck@uk-koeln.de
Cited by 1 stored of 1
1 result
No patents citing this paper on Lens.org (checked 2026-10-06).